About: novavax

Novavax starts delivering COVID vaccines to EU

US biotech firm Novavax started shipping their Novaxovid COVID-19 vaccines to EU member states on Wednesday (23 February). The first protein-based vaccine available in Europe is expected to raise vaccination rates, but its efficiency against omicron is yet to be determined.

Nuvaxovid, fifth vaccine against COVID, authorised in EU

The European Commission has granted conditional marketing authorisation for US biotech firm Novavax’s COVID-19 vaccine, Nuvaxovid, on Monday (20 December) following the European Medicines Agency (EMA) recommendation.